EUROPHARM: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
EUROPHARM
Largest movements
- Cash -€103,373
down €103,373 (-79.1%), from €130,768 to €27,395
mainly Other debts (-€90,177) and Contributions, distributions and other (-€83,046)
- Current investments -€65,948
down €65,948 (-100%), from €65,948 to €0
- Receivables within one year +€51,964
up €51,964 (+77.6%), from €66,969 to €118,934
of which Trade receivables: +€46,036
- Tangible fixed assets +€45,813
up €45,813 (+161%), from €28,537 to €74,351
of which Leasing and similar rights: +€46,487
- Other debts -€90,177
down €90,177 (-100%), from €90,177 to €0
- Debts after one year +€57,102
up €57,102 (+257%), from €22,189 to €79,291
of which Financial debts: +€39,547
- Reserves -€40,914
down €40,914 (-20.2%), from €202,448 to €161,534
- Tax, wage and social debts -€20,447
down €20,447 (-88.2%), from €23,180 to €2,733
of which Taxes: -€14,836
- Trade debts +€20,195
up €20,195 (+230%), from €8,798 to €28,993
- Gross operating margin -€21,669
down €21,669 (-20.6%), from €105,333 to €83,665
- Financial income -€14,506
down €14,506 (-71.9%), from €20,184 to €5,678
- Taxes -€8,458
down €8,458 (-30.1%), from €28,071 to €19,613
- Depreciation +€3,652
up €3,652 (+23.1%), from €15,824 to €19,476
- Financial charges +€1,567
up €1,567 (+120%), from €1,303 to €2,870
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €346,792 | €275,922 | -€70,870 | -20.4% |
| Fixed assets | 21/28 | €78,537 | €124,351 | +€45,813 | +58.3% |
| Tangible fixed assets | 22/27 | €28,537 | €74,351 | +€45,813 | +161% |
| Land and buildings | 22 | €24,437 | €20,375 | -€4,062 | -16.6% |
| Plant, machinery and equipment | 23 | €3,989 | €7,488 | +€3,500 | +87.8% |
| Furniture and vehicles | 24 | €112 | €0 | -€112 | -100% |
| Leasing and similar rights | 25 | - | €46,487 | +€46,487 | |
| Financial fixed assets | 28 | €50,000 | €50,000 | = | 0.0% |
| Current assets | 29/58 | €268,255 | €151,571 | -€116,684 | -43.5% |
| Amounts receivable within one year | 40/41 | €66,969 | €118,934 | +€51,964 | +77.6% |
| Trade receivables | 40 | €66,500 | €112,535 | +€46,036 | +69.2% |
| Other amounts receivable | 41 | €470 | €6,398 | +€5,928 | +1,262% |
| Current investments | 50/53 | €65,948 | €0 | -€65,948 | -100% |
| Cash at bank and in hand | 54/58 | €130,768 | €27,395 | -€103,373 | -79.1% |
| Deferred charges and accrued income | 490/1 | €4,569 | €5,243 | +€673 | +14.7% |
| Total equity and liabilities | 10/49 | €346,792 | €275,922 | -€70,870 | -20.4% |
| Equity | 10/15 | €202,448 | €161,534 | -€40,914 | -20.2% |
| Reserves | 13 | €202,448 | €161,534 | -€40,914 | -20.2% |
| Distributable reserves | 133 | €202,448 | €161,534 | -€40,914 | -20.2% |
| Profit (loss) carried forward | 14 | - | €0 | +€0 | |
| Amounts payable | 17/49 | €144,344 | €114,388 | -€29,956 | -20.8% |
| Amounts payable after more than one year | 17 | €22,189 | €79,291 | +€57,102 | +257% |
| Financial debts | 170/4 | - | €39,547 | +€39,547 | |
| Other amounts payable | 178/9 | €22,189 | €39,744 | +€17,555 | +79.1% |
| Amounts payable within one year | 42/48 | €122,155 | €31,726 | -€90,429 | -74.0% |
| Trade debts | 44 | €8,798 | €28,993 | +€20,195 | +230% |
| Suppliers | 440/4 | €8,798 | €28,993 | +€20,195 | +230% |
| Taxes, remuneration and social security | 45 | €23,180 | €2,733 | -€20,447 | -88.2% |
| Taxes | 450/3 | €17,569 | €2,733 | -€14,836 | -84.4% |
| Remuneration and social security | 454/9 | €5,612 | €0 | -€5,612 | -100% |
| Other amounts payable | 47/48 | €90,177 | €0 | -€90,177 | -100% |
| Accrued charges and deferred income | 492/3 | - | €3,371 | +€3,371 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €15,824 | €19,476 | +€3,652 | +23.1% |
| Other operating charges | 640/8 | €4,644 | €5,252 | +€608 | +13.1% |
| Non-recurring operating charges | 66A | €1,031 | €0 | -€1,031 | -100% |
| Gross operating margin | 9900 | €105,333 | €83,665 | -€21,669 | -20.6% |
| Operating profit (loss) | 9901 | €83,835 | €58,937 | -€24,899 | -29.7% |
| Financial income | 75/76B | €20,184 | €5,678 | -€14,506 | -71.9% |
| Recurring financial income | 75 | €20,184 | €5,678 | -€14,506 | -71.9% |
| Financial charges | 65/66B | €1,303 | €2,870 | +€1,567 | +120% |
| Recurring financial charges | 65 | €1,303 | €2,870 | +€1,567 | +120% |
| Profit (loss) for the period before taxes | 9903 | €102,716 | €61,745 | -€40,972 | -39.9% |
| Income taxes | 67/77 | €28,071 | €19,613 | -€8,458 | -30.1% |
| Profit (loss) for the period | 9904 | €74,646 | €42,132 | -€32,514 | -43.6% |
| Profit (loss) for the period to be appropriated | 9905 | €74,646 | €42,132 | -€32,514 | -43.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.